Diagnosed prevalent cases of type 1 diabetes to reach 3.166 mn in 2033: GlobalData, ET HealthWorld
New Delhi: The number of diagnosed type 1 diabetes (T1D) cases is projected to rise by 0.5per cent annually in seven major markets (7MM*), increasing from approximately 3.01 million in 2023 to 3.166 million in 2033.
GlobalData’s latest report, “Type 1 Diabetes: Epidemiology Forecast to 2033,” reveals that the increase is partly attributed to the increased life expectancy of T1D patients due to modern medicine, combined with underlying demographic changes in the respective markets.
According to GlobalData epidemiologists, the US had the highest number of diagnosed prevalent cases of T1D in 2023 with 1.77 million in 2023, whereas Japan had the lowest number of prevalent cases at 120,000.
Alia Rafiq, Epidemiologist at GlobalData, comments: “The management of T1D over the past decades has vastly improved across the 7MM. This is because T1D patients are now better able to manage their symptoms through interventions like insulin pumps, minimizing the occurrence of life-threatening conditions like diabetic ketoacidosis. As a result, T1D patients also live long enough to pass T1D-associated genes to their offspring, causing these genes to accumulate in the population.”
GlobalData epidemiologists also observed a sex difference in T1D, with men making up just over half of T1D cases in the 7MM in 2023. Conversely, Japan was the only country in 7MM in which women made up the majority of T1D diagnosed prevalent cases, with 55 per cent of cases in 2023.>
